Integrating network pharmacology and in silico analysis deciphers Withaferin-A’s anti-breast cancer potential via hedgehog pathway and target network interplay
Briefings in Bioinformatics · 2024-01-22 · 25 (2)
DOI: 10.1093/bib/bbae032 ↗At a glance
Journal article in Briefings in Bioinformatics, published online on 2024-03-05. Written by Mythili Srinivasan and 5 co-authors. Institution: Research Scholar, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra 411038, India. Major MEDLINE topics: Hedgehog Proteins, Breast Neoplasms. Cited 27 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
This study examines the remarkable effectiveness of Withaferin-A (WA), a withanolide obtained from Withania somnifera (Ashwagandha), in encountering the mortiferous breast malignancy, a global peril. The predominant objective is to investigate WA’s intrinsic target proteins and hedgehog (Hh) pathway proteins in breast cancer targeting through the application of in silico computational techniques and network pharmacology predictions. The databases and webtools like Swiss target prediction, GeneCards, DisGeNet and Online Mendelian Inheritance in Man were exploited to identify the common target proteins. The culmination of the WA network and protein–protein interaction network were devised using Stitch and String web tools, through which the drug–target network of 30 common proteins was constructed employing Cytoscape-version 3.9. Enrichment analysis was performed by incorporating Gprofiler, Metascape and Cytoscape plugins. David compounded the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes, and enrichment was computed through bioinformatics tools. The 20 pivotal proteins were docked harnessing Glide, Schrodinger Suite 2023-2. The investigation was governed by docking scores and affinity. The shared target proteins underscored the precise Hh and WA network roles with the affirmation enrichment P-value of <0.025. The implications for hedgehog and cancer pathways were profound with enrichment (P < 0.01). Further, the ADMET and drug-likeness assessments assisted the claim. Robust interactions were noticed with docking studies, authenticated through molecular dynamics, molecular mechanics generalized born surface area scores and bonds. The computational investigation emphasized WA’s credible anti-breast activity, specifically with Hh proteins, implying stem-cell-level checkpoint restraints. Rigorous testament is imperative through in vitro and in vivo studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Research Scholar, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra 411038, India.
- School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra 411038, India.
- Abhinav College of Pharmacy, Narhe, Ambegaon, Pune, Maharashtra 411041, India.
ORCID profiles: Mythili Srinivasan, Akshay M Baheti
Cite
APA
Srinivasan, M., Gangurde, A., Chandane, A. Y., Tagalpallewar, A., Pawar, A., & Baheti, A. M. (2024). Integrating network pharmacology and in silico analysis deciphers Withaferin-A’s anti-breast cancer potential via hedgehog pathway and target network interplay. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbae032
Vancouver
Srinivasan M, Gangurde A, Chandane AY, Tagalpallewar A, Pawar A, Baheti AM. Integrating network pharmacology and in silico analysis deciphers Withaferin-A’s anti-breast cancer potential via hedgehog pathway and target network interplay. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbae032
BibTeX
@article{Srinivasan2024,
author = {Srinivasan, Mythili and Gangurde, Apeksha and Chandane, Ashwini Y and Tagalpallewar, Amol and Pawar, Anil and Baheti, Akshay M},
title = {Integrating network pharmacology and in silico analysis deciphers Withaferin-A’s anti-breast cancer potential via hedgehog pathway and target network interplay},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {2},
doi = {10.1093/bib/bbae032}
}
EUVIMED